Accuray radiotherapy dose calculation software:
This article was originally published in Clinica
Executive Summary
Accuray has received 510(k) clearance from the US FDA for its dose calculation software for radiotherapy. The technology - called the Monte Carlo Dose calculation algorithm - is now available for sale worldwide, reported the company. Traditional dose calculation methods assume all photons take a single path and therefore use a single calculation to represent the dose delivered by all photons. The Monte Carlo method, however, takes into account interactions of each individual photon when considering an appropriate dose. The Sunnyvale, California firm claims it will be the first company to market the technology. The product was launched at the 9th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Barcelona, Spain, during September 8-13.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.